Cargando…
Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia
BACKGROUND AND OBJECTIVES: Entecavir is a nucleoside analog used in the treatment of chronic hepatitis B. The efficacy of ETV has not been studied in the Saudi population. The objective of the study was to find undetectable HBV DNA after 48 weeks completion of ETV treatment in real-life versus clini...
Autores principales: | Al-Ashqar, Hamad Ibrahim, Al-Quaiz, Mohammed, Dahab, Saleim Towfeig, Peedikayil, Musthafa Chalikandy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078629/ https://www.ncbi.nlm.nih.gov/pubmed/23951584 http://dx.doi.org/10.5144/0256-4947.2013.119 |
Ejemplares similares
-
Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients
por: Al Fadda, Mohammed, et al.
Publicado: (2012) -
Wilson disease in 71 patients followed for over two decades in a tertiary center in Saudi Arabia: a retrospective review
por: Al Fadda, Mohammed, et al.
Publicado: (2012) -
Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials
por: Peedikayil, Musthafa Chalikandy, et al.
Publicado: (2014) -
Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2020) -
Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents
por: Hussein, Maged H., et al.
Publicado: (2018)